Zoldonrasib: clinical trials recruiting now

3

Recruiting trials

15

Conditions studied

12

US states with sites

1

Countries

Phase breakdown

Phase 1 1 Phase 2 1 Phase 3 2

Conditions being studied

Condition	Trials
Lung cancer	2
NSCLC	2
Non-Small Cell Lung Cancer NSCLC	2
Advanced Solid Tumors	1
CRC	1
Colorectal Cancer (CRC)	1
Colorectal cancer	1
Lung Cancer (NSCLC)	1
Metastatic NSCLC - Non-Small Cell Lung Cancer	1
Metastatic Non-Squamous Non-Small Cell Lung Cancer	1
Metastatic Solid Tumors	1
Non-Squamous Non Small Cell Lung Cancer	1
Non-small Cell Lung Cancer	1
PDAC	1
PDAC - Pancreatic Ductal Adenocarcinoma	1

Recruiting trials involving Zoldonrasib

Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
NCT07777822 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
NCT07397338 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
NCT07621718 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations

Common questions

How many recruiting trials involve Zoldonrasib?

3 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.